NASDAQ:UBIO ProShares UltraPro Nasdaq Biotechnology (UBIO) Price, Holdings, & News → The #1 Biotech Stock to Have on Your Radar in 2024… (From Huge Alerts) (Ad) Free UBIO Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$17.61▼$17.6150-Day Range$17.61▼$17.7752-Week Range$13.13▼$35.36VolumeN/AAverage Volume42,922 shsMarket Capitalization$14.97 millionAssets Under Management$27.06 millionDividend Yield0.00%Net Expense Ratio0.95% Stock AnalysisStock Analysis Get ProShares UltraPro Nasdaq Biotechnology alerts: Email Address About ProShares UltraPro Nasdaq BiotechnologyRead More Ad Huge AlertsThe #1 Biotech Stock to Have on Your Radar in 2024… Revenues exploding, a $18.70 price target, and highly lucrative addressable markets make this one you cannot ignore!Learn more about why Zack’s has a BULLISH nearly $19 price target on BSEM right now! UBIO ETF News HeadlinesDecember 27, 2023 | benzinga.comMoleculin Biotech Stock (NASDAQ:MBRX) Dividends: History, Yield and DatesNovember 6, 2023 | fool.comProShares Trust - ProShares Ultra Nasdaq Cloud Computing (NASDAQ: SKYU)April 24, 2024 | Traders Agency (Ad)top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.August 8, 2023 | thestreet.comProShares UltraPro Short Nasdaq BiotechnologyJanuary 5, 2023 | benzinga.comPharmaCyte Biotech Stock (NASDAQ:PMCB), Quotes and News SummarySee More Headlines Receive UBIO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ProShares UltraPro Nasdaq Biotechnology and its competitors with MarketBeat's FREE daily newsletter. Email Address Fund Details IssuerProShares Fund NameProShares UltraPro NASDAQ Biotechnology Tax ClassificationRegulated Investment Company Stock ExchangeNASDAQCurrent SymbolNASDAQ:UBIO Inception Date6/22/2015 Fund ManagerMichael Neches, Tarak Dave WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkNASDAQ Biotechnology Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionNorth America Number of Holdings0 Fund Statistics Assets Under Management$27.06 million Average Daily Volume$58,712.30 Discount/Premium-0.04% Administrator, Advisor and Custodian AdministratorJ.P. Morgan Investor Services Co. AdvisorProShare Advisors LLC CustodianJPMorgan Chase Bank, N.A. DistributorSEI Investments Distribution Co. Transfer AgentJPMorgan Chase Bank, N.A. TrusteeN/A Lead Market MakerVirtu Financial Miscellaneous Outstanding Shares850,000BetaN/A 10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free Report Ad Huge AlertsThe #1 Biotech Stock to Have on Your Radar in 2024… Revenues exploding, a $18.70 price target, and highly lucrative addressable markets make this one you cannot ignore!Learn more about why Zack’s has a BULLISH nearly $19 price target on BSEM right now! ProShares UltraPro Nasdaq Biotechnology ExpensesTypeUBIOHealth Care ETFsEquity ETFsNASDAQ ETFsAll ETFsManagement Fee0.75%0.56%0.54%0.48%0.51%Other Expenses0.57%0.40%0.54%0.34%0.58%Total Expense1.32%0.72%0.70%0.58%0.70%Fee Waiver-0.37%-0.53%-0.55%-0.22%-0.57%Net Expense0.95%0.60%0.60%0.54%0.58% ProShares UltraPro Nasdaq Biotechnology (UBIO) ExposureUBIO Sector ExposureUBIO Industry ExposureFull Holdings Details Similar ETFsInvesco Nasdaq Biotechnology ETFNASDAQ:IBBQFirst Trust Nasdaq Pharmaceuticals ETFNASDAQ:FTXHPrincipal Healthcare Innovators ETFNASDAQ:BTECHorizon Kinetics Medical ETFNASDAQ:MEDXJPMorgan Healthcare Leaders ETFNASDAQ:JDOC UBIO ETF - Frequently Asked Questions What does UBIO invest in? ProShares UltraPro Nasdaq Biotechnology is a equity fund issued by ProShares. UBIO focuses on health care investments and follows the NASDAQ Biotechnology Index. The fund's investments total to approximately $27.06 million assets under management. What is the management fee for ProShares UltraPro Nasdaq Biotechnology? ProShares UltraPro Nasdaq Biotechnology's management fee is 0.75% and has other expenses of 0.57%. However, UBIO has a fee waiver of -0.37% to reimburse the expenses. The net expense ratio for UBIO is 0.95%. What other stocks do shareholders of ProShares UltraPro Nasdaq Biotechnology own? Based on aggregate information from My MarketBeat watchlists, some companies that other ProShares UltraPro Nasdaq Biotechnology investors own include Shopify (SHOP), Energous (WATT), Arista Networks (ANET), Markel Group (MKL), NVIDIA (NVDA), Block (SQ), VMware (VMW), Adobe (ADBE) and Aimmune Therapeutics (AIMT). This page (NASDAQ:UBIO) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Have on Your Radar in 2024… Huge AlertsHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersFed launches fourth dollar overhaulStansberry ResearchThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ProShares UltraPro Nasdaq Biotechnology Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
